AFP、AFU、SF联检对原发性肝癌的诊断价值  

Clinical Value of Combined Measurement of Serum Alpha-Fetoprotein,Alpha-L-Fucosidase and Ferritin Levels in the Diagnosis of Primary Liver Cancer

作　　者：张爱民[1] 柴小红[1] 靳颖[1] 董雪梅[1] 

机构地区：[1]武警医学院附属医院检验科,300162

出　　处：《放射免疫学杂志》2005年第6期432-434,共3页Journal of Radioimmanology

摘　　要：目的:探讨血清甲胎蛋白(AFP)、α-L-岩藻糖苷酶(AFU)和铁蛋白(SF)联检对提高原发性肝癌阳性检出率的意义。方法:检测52例原发性肝癌患者和40例正常对照组血清AFP、AFU、SF的含量。结果:AFP、AFU、SF三项指标对原发性肝癌患者的阳性率分别为82.7%、86.5%、76.9%。AFP+AFU、AFP+SF、AFP+AFU+SF联检阳性率分别为94.2%、90.4%、98.1%。结论:血清AFP、AFU、SF联检可提高对原发性肝癌的诊断阳性率。Objective To investigate the clinical value of combined measurement of serum alpha - fetoprotein （ AFP）, alpha - L -fucosidase （AFU） and ferritin （SF） levels in the diagnosis of primary liver cancer. Methods Serum AFP, AFU （with RIA） and SF （with biochemical method） were determined in 52 patients with primary liver cancer and 40 controls. Results The positive rates of AFP, AFU and SF in patient with liver cancer were 82.7%, 86.6% and 76.9%, respectively. Positive rates with combined measurement of AFP plus AFU, AFP plus SF, and AFP plus AFU, SF were 94.2%, 90.4% and 98.1% respectively. Conclusion Combined t of AFP. AFU and SF can significantlv increase the positive rate in the diagnosis of primary liver cancer

关 键 词：原发性肝癌 甲胎蛋白 Α-L-岩藻糖苷酶 铁蛋白 

分 类 号：R735.7[医药卫生—肿瘤] R512.62[医药卫生—临床医学]